about
The causative H+/K+ ATPase antigen in the pathogenesis of autoimmune gastritis.Autoantibodies in neuropsychiatric lupus.Pernicious anaemia.Experimental autoimmune gastritis: mouse models of human organ-specific autoimmune disease.Reversing the autoimmune condition: experience with experimental autoimmune gastritis.The Influence of Differentially Expressed Tissue-Type Plasminogen Activator in Experimental Autoimmune Encephalomyelitis: Implications for Multiple Sclerosis.Tweaking the immune system: gene therapy-assisted autologous haematopoietic stem cell transplantation as a treatment for autoimmune disease.Cutting edge issues in autoimmune gastritis.Hematopoietic stem cell gene therapy as a treatment for autoimmune diseases.Efficient conditional gene expression following transplantation of retrovirally transduced bone marrow stem cells.Transplantation of autoimmune regulator-encoding bone marrow cells delays the onset of experimental autoimmune encephalomyelitis.Targeting MOG expression to dendritic cells delays onset of experimental autoimmune disease.Alpha and beta subunits of the gastric H+/K(+)-ATPase are concordantly targeted by parietal cell autoantibodies associated with autoimmune gastritis.Tackling autoimmunity with gene therapyStem cells engineered to express self-antigen to treat autoimmunity.Gene therapy delivery of myelin oligodendrocyte glycoprotein (MOG) via hematopoietic stem cell transfer induces MOG-specific B cell deletion.Transplantation of bone marrow genetically engineered to express proinsulin II protects against autoimmune insulitis in NOD mice.Non-myeloablative transplantation of bone marrow expressing self-antigen establishes peripheral tolerance and completely prevents autoimmunity in mice.Nonmyeloablative conditioning generates autoantigen-encoding bone marrow that prevents and cures an experimental autoimmune disease.Gene therapy and bone marrow stem-cell transfer to treat autoimmune disease.Methylprednisolone induces reversible clinical and pathological remission and loss of lymphocyte reactivity to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis.Tolerance established in autoimmune disease by mating or bone marrow transplantation that target autoantigen to thymus.Fas/CD95 is required for gastric mucosal damage in autoimmune gastritis.Autoantibodies to neurons and to the cytoskeleton in small cell carcinoma with paraneoplastic sensory neuropathy.Transplantation of retrovirally transduced bone marrow prevents autoimmune disease in aged mice by peripheral tolerance mechanisms.Chemokine receptor CCR5 is not required for development of experimental autoimmune gastritis.GM-CSF-induced autoimmune gastritis in interferon α receptor deficient miceA novel method for isolating mononuclear cells from the stomachs of mice with experimental autoimmune gastritisExpression of a gastric autoantigen in pancreatic islets results in non-destructive insulitis after neonatal thymectomyAnalysis of mononuclear cell infiltrate and cytokine production in murine autoimmune gastritisOrgan-specific autoimmunity induced by adult thymectomy and cyclophosphamide-induced lymphopeniaTumor necrosis factor alpha is not implicated in the genesis of experimental autoimmune gastritisOrgan-specific autoimmunity in granulocyte macrophage-colony stimulating factor (GM-CSF) deficient micePrednisolone promotes remission and gastric mucosal regeneration in experimental autoimmune gastritisStem cell based therapy for autoimmunity
P50
Q33953206-360943CE-BEA9-46EE-8859-BDB8846890FAQ34692563-D913F523-BA55-4F44-AA31-4BD7761FBB6BQ35934772-BB64D845-1436-4E3D-8480-AAD004C089FAQ36069509-56D1A051-9FE8-4EEF-873E-69801A660324Q36069520-20989981-E315-4063-BD80-BB522FADC882Q36079853-D5E1C11B-9726-4AFE-B088-2C8FADA29873Q37311069-853DC052-FF47-4A02-8D76-E866D6FCEFE9Q37822712-11537E90-5750-4DC7-B3EA-F1D739F6A764Q37898100-2BCB0788-F7C2-443F-92DA-E51FA9CC4EB8Q38935936-52BCDB31-92F5-4896-B800-9216DA7D6BC4Q39627505-B08CB499-17D3-48B2-BA0C-D5680513BA5EQ39649689-B548036F-D256-4627-A2B3-38CA8233359DQ41588479-2596B50C-673A-4EDA-9A20-54F32DBAC7EEQ41832415-5B4D1EE8-7080-4C6A-8AF1-780B54C2ABE3Q45861637-31588FE4-671B-4713-B03B-499035264B65Q45862484-7D971A71-C992-4905-9851-ADF62B69C6BFQ45862670-382B6E43-5906-4A4B-B777-C47FE207881DQ45874884-7053A6B9-791C-4AD7-AFE2-CF50088823D2Q45879745-EB55BB56-0ECE-4990-90DE-34D26E5F9C87Q45887583-6A4389C8-026C-4BF8-BF82-AFFFE893C282Q46528181-776B05CA-F18C-4883-A83F-C44539E9664EQ53941539-3DBC99AD-CE15-4BFF-83D0-BC3799AE1FF5Q53960706-44CAB055-E279-4FC4-BEB6-4E36C465AFFAQ53993447-E01E94D9-7DCB-4835-8C11-89367CF389E6Q54605762-B8066A04-2E62-40BE-B211-34226B922C49Q54745308-E97B3992-0061-4EA1-8899-6F49B659C3E5Q57272372-F532C3E8-369C-4F93-913A-5AF91BF30517Q71569656-59517D78-BCC0-4C48-9DCE-DB1E565960A1Q71815215-F017262D-CE3A-456D-905E-4A05E7512B94Q71884836-CD7E4213-12C6-42C1-BD07-096A22133126Q72508275-426FC3F8-4DD2-4892-B1B8-37926B053A63Q75227679-51C74E89-6879-4E3E-865A-7AEBD9EE12E5Q77805696-319BEE58-461B-466F-B2B1-5585961E20DBQ83370339-3E56147F-D2B6-44D9-A039-2C172578C8AEQ85212092-CCFBA258-9563-4F7C-8A49-328F5E701CA9
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Frank Alderuccio
@ast
Frank Alderuccio
@en
Frank Alderuccio
@es
Frank Alderuccio
@nl
Frank Alderuccio
@sl
type
label
Frank Alderuccio
@ast
Frank Alderuccio
@en
Frank Alderuccio
@es
Frank Alderuccio
@nl
Frank Alderuccio
@sl
prefLabel
Frank Alderuccio
@ast
Frank Alderuccio
@en
Frank Alderuccio
@es
Frank Alderuccio
@nl
Frank Alderuccio
@sl
P106
P1153
7003963508
P21
P31
P496
0000-0003-4853-3394